These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 8895749)
21. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo. Ishida H; Nakata T; Sato N; Li PK; Kuwabara T; Akinaga S Breast Cancer Res Treat; 2007 Aug; 104(2):211-9. PubMed ID: 17061037 [TBL] [Abstract][Full Text] [Related]
23. Steroid sulfatase: a new target for the endocrine therapy of breast cancer. Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer. Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823 [TBL] [Abstract][Full Text] [Related]
25. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Nicolas LB; Pinoteau W; Papot S; Routier S; Guillaumet G; Mortaud S Brain Res; 2001 Dec; 922(2):216-22. PubMed ID: 11743952 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells. Selcer KW; Kabler H; Sarap J; Xiao Z; Li PK Steroids; 2002 Sep; 67(10):821-6. PubMed ID: 12231117 [TBL] [Abstract][Full Text] [Related]
28. Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity. Fischer DS; Chander SK; Woo LW; Fenton JC; Purohit A; Reed MJ; Potter BV J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):343-9. PubMed ID: 12711021 [TBL] [Abstract][Full Text] [Related]
29. Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate. Li PK; Rhodes ME; Jagannathan S; Johnson DA Brain Res Cogn Brain Res; 1995 Oct; 2(4):251-4. PubMed ID: 8580738 [TBL] [Abstract][Full Text] [Related]
30. Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker. Ciobanu LC; Poirier D J Comb Chem; 2003; 5(4):429-40. PubMed ID: 12857111 [TBL] [Abstract][Full Text] [Related]
31. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor. Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286 [TBL] [Abstract][Full Text] [Related]
32. Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates. Okada M; Nakagawa T; Iwashita S; Takegawa S; Fujii T; Koizumi N J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):141-8. PubMed ID: 14672734 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer. Foster PA; Chander SK; Parsons MF; Newman SP; Woo LW; Potter BV; Reed MJ; Purohit A Breast Cancer Res Treat; 2008 Sep; 111(1):129-38. PubMed ID: 17914670 [TBL] [Abstract][Full Text] [Related]
34. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors. Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035 [TBL] [Abstract][Full Text] [Related]
35. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors. Ciobanu LC; Boivin RP; Luu-The V; Poirier D J Enzyme Inhib Med Chem; 2003 Feb; 18(1):15-26. PubMed ID: 12751816 [TBL] [Abstract][Full Text] [Related]
36. Development of potent non-estrogenic estrone sulfatase inhibitors. Li PK; Chu GH; Guo JP; Peters A; Selcer KW Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650 [TBL] [Abstract][Full Text] [Related]
37. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential. Thomas MP; Potter BV J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211 [TBL] [Abstract][Full Text] [Related]
38. Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2). Wong CK; Keung WM Biochem Biophys Res Commun; 1997 Apr; 233(3):579-83. PubMed ID: 9168894 [TBL] [Abstract][Full Text] [Related]
39. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. MacIndoe JH Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800 [TBL] [Abstract][Full Text] [Related]
40. Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitors. Cozier GE; Leese MP; Lloyd MD; Baker MD; Thiyagarajan N; Acharya KR; Potter BV Biochemistry; 2010 Apr; 49(16):3464-76. PubMed ID: 20297840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]